Surgery Partners.
healthcare services company
- Reports this week
- 0
- Active events
- 1
- Connections
- 38
What's happening
Active this week
Earlier this month
One to three months ago
-
Surgery Partners underperformed the market so far this year, based on events of August 5, 2025.Some support2 reports
-
Surgery Partners is listed on NASDAQ and receives analyst ratings from MarketBeat.Some support2 reports
-
Cantor Fitzgerald is monitoring the performance of Surgery Partners, a healthcare services provider in the US. Raymond James Financial and TD Cowen are also providing price targets and buy ratings.Some support1 report
-
Surgery Partners (Q124668353) is expected to divest from Idaho Falls (Q496360) and operates on the Nasdaq stock exchange (Q82059).Some support1 report
-
Eric J. Evans was appointed CEO and Dave Doherty was appointed CFO of Surgery Partners on August 5, 2025.Some support2 reports
-
Surgery Partners is selling facilities to Intermountain Health.Some support1 report
-
Analyst reports from Jefferies Financial Group influence stock price targets for Surgery Partners.Some support2 reports
Gone quiet
No new reports in 90+ days-
A tariff plan could affect the healthcare supply chain, impacting companies like Nobel Biocare and Cardinal Health.Some support2 reports
-
Surgery Partners and Pacific Biosciences were both mentioned in the context of healthcare industry performance in July 2025.Speculative1 report
-
Surgery Partners operates across 33 states in the US, and DaVita operates over 2,600 dialysis centers in the US.Some support1 report
-
Surgery Partners is headquartered in Brentwood, Tennessee, and uses Replay for conference call distribution.Some support2 reports
-
Surgery Partners's stock return outpaced the S&P 500 on July 22, 2025.Some support1 report
-
Surging medical costs are impacting the health insurance sector, involving companies like UnitedHealth Group, Molina Healthcare, Moderna, Oscar Health, and Surgery Partners.Some support2 reports2 developments inside
-
Surgery Partners rejected a buyout offer from Bain Capital, while Benchmark reiterated a 'Buy' rating on the company.Some support4 reports
-
Surgery Partners and Select Medical are identified as operating in the healthcare providers and services segment.Some support1 report
-
Surgery Partners and Lifestance Health are partnering, both of which operate in the outpatient and specialty care segment.Some support3 reports1 development inside
-
Rate cut speculation on August 14, 2025, benefited growth sectors, including healthcare companies like Clover Health, Surgery Partners, Illumina, and Bruker.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Surgery Partners this week
News at the entities that move Surgery Partners most-
SEC StructuralDHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Moves Surgery Partners
-
Jefferies Financial Group StructuralApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Surgery Partners
-
Cantor Fitzgerald Mentioned togetherAnalyst firm lowered price targets on Automatic Data Processing (ADP) stock on June 6, 2026.Moves Surgery Partners
-
Benchmark Mentioned togetherMarketBeat published a buy rating and target price increase for a company, with disclosures made under a Rule 10b5-1 trading plan.Moves Surgery Partners
-
TD Cowen Mentioned togetherAnalyst downgraded Ag Growth International Inc. due to debt management risks.Moves Surgery Partners
-
Bain Capital TransactionalArdian and Bain Capital discussed exit strategies within the private markets sector.Moves Surgery Partners
Connections
The 15 strongest of 38, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Eric Evans Structural
Eric Evans holds the role of Chief Executive Officer of Surgery Partners, leading company operations and strategic direction.
-
Bain Capital Transactional
Bain Capital attempted to acquire Surgery Partners, holding a 39% stake before the buyout offer was rejected.
-
Benchmark Mentioned together
Benchmark provides investment ratings and analysis on Surgery Partners.
-
SEC Structural
Surgery Partners is subject to SEC filing requirements for market transparency.
-
TD Cowen Mentioned together
TD Cowen provides financial ratings and price targets for Surgery Partners.
-
Jefferies Financial Group Structural
Analyst reports from Jefferies Financial Group are utilized by the market to influence stock price targets for Surgery Partners.
-
Cantor Fitzgerald Mentioned together
Cantor Fitzgerald provides financial coverage, including 'Overweight' ratings and price targets, for Surgery Partners.
-
ASC Operational
Evidence suggests Surgery Partners is strategically targeting ASC's market influence and professional sphere.
Show all 15 connections
-
FED Shared context
Surgery Partners operates within the macroeconomic environment influenced by FED policy.
-
Raymond James Financial Mentioned together
Raymond James Financial provides market coverage including price targets and ratings for Surgery Partners.
-
Fifth Third Bancorp Transactional
One company increased its holdings in the other company's stock.
-
Nasdaq Shared context
Surgery Partners is a company listed and trades on the Nasdaq stock exchange.
-
UnitedHealth Group Mentioned together
The entities are co-mentioned in the context of the broader health insurance industry and medical costs.
-
Idaho Falls Shared context
Surgery Partners is operating within the geographical context of Idaho Falls, which is the focus of a pending business transaction.
-
MarketBeat Mentioned together
MarketBeat provides analyst ratings and market coverage for Surgery Partners.
History
Events by the month they beganSeptember 2026
2 eventsAugust 2026
3 events- Surgery Partners is listed on NASDAQ and receives analyst ratings from MarketBeat.
- Cantor Fitzgerald is monitoring the performance of Surgery Partners, a healthcare services provider in the US. Raymond James Financial and TD Cowen are also providing price targets and buy ratings.
- Surgery Partners (Q124668353) is expected to divest from Idaho Falls (Q496360) and operates on the Nasdaq stock exchange (Q82059).
July 2026
2 eventsShow 1 earlier month
June 2026
12 events- Surgery Partners underperformed the market so far this year, based on events of August 5, 2025.
- Eric J. Evans was appointed CEO and Dave Doherty was appointed CFO of Surgery Partners on August 5, 2025.
- A tariff plan could affect the healthcare supply chain, impacting companies like Nobel Biocare and Cardinal Health.
- Surgery Partners and Pacific Biosciences were both mentioned in the context of healthcare industry performance in July 2025.
- Surgery Partners operates across 33 states in the US, and DaVita operates over 2,600 dialysis centers in the US.
- Surgery Partners is headquartered in Brentwood, Tennessee, and uses Replay for conference call distribution.
- Surgery Partners's stock return outpaced the S&P 500 on July 22, 2025.
- Surging medical costs are impacting the health insurance sector, involving companies like UnitedHealth Group, Molina Healthcare, Moderna, Oscar Health, and Surgery Partners.
- Surgery Partners rejected a buyout offer from Bain Capital, while Benchmark reiterated a 'Buy' rating on the company.
- Surgery Partners and Select Medical are identified as operating in the healthcare providers and services segment.
- Surgery Partners and Lifestance Health are partnering, both of which operate in the outpatient and specialty care segment.
- Rate cut speculation on August 14, 2025, benefited growth sectors, including healthcare companies like Clover Health, Surgery Partners, Illumina, and Bruker.